2013
DOI: 10.4103/1658-600x.120848
|View full text |Cite
|
Sign up to set email alerts
|

Evaluation of selected trace elements in male type 2 diabetic patients in Nnewi, south eastern Nigeria

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

2
3
1

Year Published

2016
2016
2023
2023

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(8 citation statements)
references
References 0 publications
2
3
1
Order By: Relevance
“…In contrast, serum LH, FSH, and PRL concentrations should typically be between 1.4 and 18.1 mIU/mL, 1.5 to 9.3 mIU/mL, and 2.1 to 17.7 ng/mL, respectively (Chmitt et al, 2011). The current findings are consistent with earlier research that found lower testosterone levels (Rosen, 2004;Dhindsa et al, 2005;Stanworth & Jones 2009a;Stanworth et al, 2009b), higher prolactin serum levels (Mooradian et al, 1985;Onah et al, 2013;Rasheed et al, 2019), higher FSH level, and no significant difference in LH level (Onah et al, 2013). Other studies have shown, in contrast to our results, that type-2 diabetic patients have significant decreases in LH and FSH compared with healthy controls (Almihy et al, 2015;Xiaoxia et al,2017); type-2 people with diabetes have significantly higher LH levels than controls (Natah et al,2013); and there are no significant differences between type-2 diabetics and non-diabetics in serum levels of FSH and Te (Baccetti et al, 2002), (Rezvani, 2012).…”
Section: Resultssupporting
confidence: 93%
“…In contrast, serum LH, FSH, and PRL concentrations should typically be between 1.4 and 18.1 mIU/mL, 1.5 to 9.3 mIU/mL, and 2.1 to 17.7 ng/mL, respectively (Chmitt et al, 2011). The current findings are consistent with earlier research that found lower testosterone levels (Rosen, 2004;Dhindsa et al, 2005;Stanworth & Jones 2009a;Stanworth et al, 2009b), higher prolactin serum levels (Mooradian et al, 1985;Onah et al, 2013;Rasheed et al, 2019), higher FSH level, and no significant difference in LH level (Onah et al, 2013). Other studies have shown, in contrast to our results, that type-2 diabetic patients have significant decreases in LH and FSH compared with healthy controls (Almihy et al, 2015;Xiaoxia et al,2017); type-2 people with diabetes have significantly higher LH levels than controls (Natah et al,2013); and there are no significant differences between type-2 diabetics and non-diabetics in serum levels of FSH and Te (Baccetti et al, 2002), (Rezvani, 2012).…”
Section: Resultssupporting
confidence: 93%
“…These results are similar to others [12][13][14][15][16][17][18] . But some study did not find difference in serum chromium and selenium levels in between type 2 diabetic subjects and healthy control 19,20 .…”
Section: Discussionsupporting
confidence: 93%
“…This prolonged hyperglycemia increases the osmotic pressure of kidney tubules that inhibits the reabsorption of water by the kidney, resulting polyuria. Due to this polyuria increased excretion of chromium and selenium occur in type 2 diabetic patients [21][22][23][24] . As a result lower serum chromium and selenium levels increase the risk of diabetic complications like atherosclerosis, hypertension and coronary heart disease in type 2 diabetes mellitus.…”
Section: Discussionmentioning
confidence: 99%
“…Higher mean serum zinc level of male diabetic patients in comparison to healthy controls was noticed in this study. This finding contrast with study carried out in Nnewi, in which they found that the concentrations of serum Zn in male patients with T2D are significantly lower than control subjects [8]. This may suggest that profiles differs among populations residing in different states, it may be related to variation in dietary composition according to state of residence.…”
Section: Discussioncontrasting
confidence: 80%